Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ASURAGEN INCORPORATED
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-10-01 to 2025-09-30
Current total value of award: $477508
Description: QUANTIDEX QPCR BCR ABL IS KIT - EXERCISE THE FY25 OPTION YEAR.